General Information of the Protein
| Protein ID |
PT01670
|
||||
|---|---|---|---|---|---|
| Protein Name |
Calcitonin gene-related peptide type 1 receptor
|
||||
| Secondarily Protein Name |
Calcitonin receptor-like receptor
|
||||
| Gene Name |
CALCRL
|
||||
| Secondarily Gene Name |
CGRPR
|
||||
| Sequence |
MEKKCTLYFLVLLPFFMILVTAELEESPEDSIQLGVTRNKIMTAQYECYQKIMQDPIQQAEGVYCNRTWDGWLCWNDVAAGTESMQLCPDYFQDFDPSEKVTKICDQDGNWFRHPASNRTWTNYTQCNVNTHEKVKTALNLFYLTIIGHGLSIASLLISLGIFFYFKSLSCQRITLHKNLFFSFVCNSVVTIIHLTAVANNQALVATNPVSCKVSQFIHLYLMGCNYFWMLCEGIYLHTLIVVAVFAEKQHLMWYYFLGWGFPLIPACIHAIARSLYYNDNCWISSDTHLLYIIHGPICAALLVNLFFLLNIVRVLITKLKVTHQAESNLYMKAVRATLILVPLLGIEFVLIPWRPEGKIAEEVYDYIMHILMHFQGLLVSTIFCFFNGEVQAILRRNWNQYKIQFGNSFSNSEALRSASYTVSTISDGPGYSHDCPSEHLNGKSIHDIENVLLKPENLYN
Show/Hide
|
||||
| Organism |
Homo sapiens, Human
|
||||
| Protein Classification |
Membrane receptor
>
Family B G protein-coupled receptor
>
Peptide receptor (family B GPCR)
>
Calcitonin-like receptor
>
Calcitonin gene-related peptide receptor
|
||||
| Function |
Receptor for calcitonin-gene-related peptide (CGRP) together with RAMP1 and receptor for adrenomedullin together with RAMP3 (By similarity). Receptor for adrenomedullin together with RAMP2 (PubMed:22102369, PubMed:30115739). The activity of this receptor is mediated by G proteins which activate adenylyl cyclase (PubMed:22102369, PubMed:30115739).
Show/Hide
|
||||
| Uniprot ID |
Show/Hide
|
||||
| Ensembl ID | |||||
| HGNC ID | |||||
| Subcellular Location |
Cell membrane
|
||||
Map of Molecular Bioactivity Related to the Protein
|
Map of Molecular Bioactivity Related to the Protein Protein Cell Line Compound Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
|---|
Table of Molecular Bioactivities Related to the Protein
Cell Line ID: CL000011 , CHO
Cell Line ID: CL000006 , HEK293
Cell Line ID: CL000748 , NAL1A clone C4E10
Cell Line ID: CL000074 , SK-N-MC
Biochemical Assays
Clinical Information about the Protein
Target 1 ( Calcitonin gene-related peptide receptor (CGRPR) )
| Target Type | Successful Target | ||||
|---|---|---|---|---|---|
| Disease | 2 Target-related Diseases | 2 | |||
| 1 | Migraine [ICD-11: 8A80] | ||||
| 2 | Cluster headache [ICD-11: 8A81.0] | ||||
| Approved Drug(s) | 4 Approved Drugs | 4 | |||
| 1 | Rimegepant | Approved | |||
| 2 | Ubrogepant | Approved | |||
| 3 | Atogepant | Approved | |||
| 4 | Zavegepant | Approved | |||
| Clinical Trial Drug(s) | 3 Clinical Trial Drugs | 3 | |||
| 1 | MK-3207 | Phase 2 | |||
| 2 | Olcegepant | Phase 2 | |||
| 3 | Telcagepant | Phase 2 | |||
| Investigative Drug(s) | 1 Investigative Drug | 1 | |||
| 1 | BMS-694153 | Investigative | |||
Target 2 ( HUMAN calcitonin gene-related peptide type 1 receptor (CALCRL) )
| Target Type | Unknown Type Target | ||||
|---|---|---|---|---|---|